Earnings Call · Q4 FY2023·2024-02-20

Q4 23EPS -33.33%·Rev n/aQ3 23EPS +23.08%·Rev n/aQ2 23EPS +8.33%·Rev n/aQ1 23EPS -7.69%·Rev n/a⚠ consensus missing

AbCellera Biologics Inc. ABCL

Tryn Stimart — Chief Legal and Compliance Officer

Carl Hansen — President

Andrew Booth — Chief Financial Officer

−0.6%1d on move date0.0% vs SPY3d−9.2%5d−7.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABCL calls or request research access.

More ABCL calls Browse calls Request research access